Regulus Btn


Briefcase Shareholder Briefcase
Email Alerts E-Mail Alerts
Download Center Download Library
RSS News Feeds


(NASDAQ:ISIS) as of 4:08 PM ET on 07/02/02009
Last: 15.83 Change: $0.49 down  (3.00%)
Day High: 16.19 Day Low: 15.67


Recent Releases
06/11/09 Isis Pharmaceuticals to Present at Jefferies' 3rd Annual Healthcare Conference
06/09/09 Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
06/05/09 Isis Pharmaceuticals to Present at Needham's 8th Annual Life Sciences Conference
 
Analyst Firm Phone
James Birchenough Barclays Capital   415-274-5393
Debjit Chattopadhyay Boenning & Scattergood, Inc.   610-684-5417
Hamed Khorsand BWS Financial Inc.   818-332-9696
Lucy Lu Citigroup Global Markets   212-816-1441
Salveen Kochnover Collins Stewart LLC   212-389-8052
Eric Schmidt Cowen and Co., LLC   646-562-1345
Alex To Cross Current Research LLC   609-243-0082
Eun Yang Jefferies & Company   212-284-2264
Joseph Schwartz Leerink Swann & Company   617-918-4575
Shiv Kapoor Morgan Joseph & Co. Inc.   917-238-8207
Mark Monane Needham & Company   212-705-0346
Edward Tenthoff Piper Jaffray & Co.   212-284-9403
Carol Werther Summer Street Research Partners   617-532-6418
Ian Somaiya Thomas Weisel Partners   212-271-3761
Aaron Reames Wachovia Capital Markets, LLC   617-603-4219

Contact Us
Kristina Lemonidis
Director, Investor Relations

Telephone: 760-603-2331
E-mail: info@isisph.com